Spinal Fusion: Implanted Instrumentation
Spinal Fusion: Implanted Instrumentation
$4,750.00
n 2021, global sales of spinal fusion implanted instrumentation were estimated at $4.3bn. Growth in the market is being driven by an aging demographic and the rising prevalence of degenerative disc disease. Factors that are limiting growth include pricing pressure from the numerous suppliers in the market as well as competition from motion-preserving implants such as artificial discs.
Publisher: Meddevicetracker
- Highlights
- Description
- Contents
This medical market and technology report provides a comprehensive discussion of implanted instrumentation for spinal fusion. This market consists of:
- spinal plating systems
- intervertebral body fusion devices (IBFDs)
- pedicle screw/posterior spinal fixation systems.
Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets, which includes all other
countries.
This report provides the following useful information:
- back pain prevalence data
- osteoarthritis prevalence data
- spinal fusion procedure volumes
- product portfolios offered by leading manufacturers
- in-depth market and competitive analyses.
Overview
In 2021, global sales of spinal fusion implanted instrumentation were estimated at $4.3bn. Growth in the market is being driven by an aging demographic and the rising prevalence of degenerative disc disease. Factors that are limiting growth include pricing pressure from the numerous suppliers in the market as well as competition from motion-preserving implants such as artificial discs. This report includes an analysis of products, current/forecast markets, competitors, and opportunities in the global market for spinal fusion implanted instrumentation, including spinal plating systems, intervertebral body fusion devices, and pedicle screw/posterior spinal fixation systems. Regional markets covered by this analysis include the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world market, which includes all other countries. The forecast range for this report is 2021–26.
Table of Contents
Executive Summary…………………………………………………………………………………………………………….ES-1
i. Spinal fusion implanted instrumentation market …………………………………………………………..ES-1
a. Other selected market drivers and limiters…………………………………………………ES-4
b. Market leaders………………………………………………………………………………………..ES-5
ii. Methodology ……………………………………………………………………………………………………………ES-7
Exhibit ES-1: Spinal fusion instrumentation, combined market forecast, by product segment ($m), 2021–26 …………………………………………………………………………………………………………ES-2
Exhibit ES-2: Spinal fusion instrumentation, combined market forecast, by region ($m), 2021–26 …………………………………………………………………………………………………………ES-3
Exhibit ES-3: Spinal fusion instrumentation market, combined share by supplier, 2021………………ES-6
1. Clinical Overview…………………………………………………………………………………………………………….. 1-1
1.1 Spinal anatomy……………………………………………………………………………………………………….. 1-4
1.2 Selected spinal disorders………………………………………………………………………………………….. 1-7
1.2.1 Disc herniation……………………………………………………………………………………. 1-7
1.2.2 Degenerative disc disease…………………………………………………………………….. 1-8
1.2.3 Abnormal curvature of the spine…………………………………………………………. 1-12
1.2.4 Spondylolisthesis……………………………………………………………………………….. 1-13
1.2.5 Stenosis……………………………………………………………………………………………. 1-14
1.2.6 Spinal tumors……………………………………………………………………………………. 1-14
1.2.7 Traumatic spinal injuries…………………………………………………………………….. 1-15
1.3 Spinal fusion …………………………………………………………………………………………………………. 1-15
1.3.1 Procedure volumes……………………………………………………………………………. 1-16
1.4 Bibliography………………………………………………………………………………………………………….. 1-20
Exhibit 1-1: Low back pain prevalence in the US, Japan, and five major European markets, 2010 and 2017………………………………………………………………………………………………….. 1-1
Exhibit 1-2: Low back pain, disability-adjusted life years, in the US, Japan, and five major European markets, 2017……………………………………………………………………………………. 1-2
Exhibit 1-3: Neck pain prevalence in the US, Japan, and five major European markets, 2010 and 2017………………………………………………………………………………………………….. 1-3
Exhibit 1-4: The human spine ………………………………………………………………………………………………. 1-6
Exhibit 1-5: Osteoarthritis prevalence in the US, Japan, and five major European markets, 2010 and 2017………………………………………………………………………………………………… 1-10
Exhibit 1-6: Prevalent cases of osteoporosis in the US, Japan, and five major European markets, forecast by country, 2021–26 …………………………………………………………………………… 1-12
Exhibit 1-7: Spinal fusion, procedure volumes forecast, by region, 2021–26 ……………………………. 1-18
2. Spinal Fusion: Implanted Instrumentation Market………………………………………………………………. 2-1
2.1 Market analysis……………………………………………………………………………………………………….. 2-1
2.2 Competitive analysis………………………………………………………………………………………………… 2-6
2.3 Spinal plating systems……………………………………………………………………………………………… 2-8
2.3.1 Products…………………………………………………………………………………………….. 2-9
2.3.2 Market analysis…………………………………………………………………………………. 2-12
2.3.3 Competitive analysis………………………………………………………………………….. 2-14
2.4 Interbody fusion devices………………………………………………………………………………………… 2-15
2.4.1 Products…………………………………………………………………………………………… 2-16
2.4.2 Market analysis…………………………………………………………………………………. 2-21
2.4.3 Competitive analysis………………………………………………………………………….. 2-23
2.5 Pedicle screws/posterior spinal fixation devices………………………………………………………… 2-25
2.5.1 Products…………………………………………………………………………………………… 2-26
2.5.2 Market analysis…………………………………………………………………………………. 2-30
2.5.3 Competitive analysis………………………………………………………………………….. 2-30
2.6 Company revenues and commentary ………………………………………………………………………. 2-33
2.6.1 Medtronic ………………………………………………………………………………………… 2-33
2.6.2 DePuy Synthes/Johnson & Johnson……………………………………………………… 2-36
2.6.3 Stryker……………………………………………………………………………………………… 2-37
2.6.4 Other leading competitors………………………………………………………………….. 2-39
2.7 Bibliography………………………………………………………………………………………………………….. 2-44
Exhibit 2-1: Spinal fusion instrumentation, combined market forecast, by product segment ($m), 2021–26 …………………………………………………………………………………………………………… 2-4
Exhibit 2-2: Spinal fusion instrumentation, combined market forecast, by region ($m), 2021–26 …………………………………………………………………………………………………………… 2-5
Exhibit 2-3: Spinal fusion instrumentation market, combined share by supplier, 2021 ……………….. 2-7
Exhibit 2-4: Classification of anterior column plating systems………………………………………………….. 2-8
Exhibit 2-5: Selected spinal plating systems…………………………………………………………………………… 2-9
Exhibit 2-6: Medtronic’s Atlantis Vision Elite anterior cervical plate system…………………………….. 2-12
Exhibit 2-8: Spinal plating systems, share by supplier, 2021…………………………………………………… 2-14
Exhibit 2-9: DePuy Synthes’ BENGAL stackable cage system ………………………………………………….. 2-15
Exhibit 2-10: Selected minimally invasive interbody fusion systems ……………………………………….. 2-17
Exhibit 2-11: Selected interbody fusion and spacer devices …………………………………………………… 2-18
Exhibit 2-12: Interbody fusion devices, market forecast, by region ($m), 2021–26 …………………… 2-22
Exhibit 2-13: Intervertebral body fusion devices, share by supplier, 2021 ……………………………….. 2-24
Exhibit 2-14: Selected thoracolumbar fixation/pedicle screw systems…………………………………….. 2-26
Exhibit 2-15: ATEC Spine’s Arsenal spinal fixation system………………………………………………………. 2-28
Exhibit 2-16: Selected posterior cervicothoracic fixation and pedicle screw systems………………… 2-29
Exhibit 2-17: Pedicle screw/posterior fixation systems, market forecast, by region ($m), 2021–26 ……………………………………………………………………………………………………….. 2-31
Exhibit 2-18: Pedicle screw/posterior fixation systems, share by supplier, 2021 ………………………. 2-32
Exhibit 2-19: Medtronic net sales, by product category and geography ($m), FY2020–22 …………. 2-34
Exhibit 2-20: Johnson & Johnson’s Medical Devices business sector net sales, by product category and geography ($m), 2019–21 …………………………………………… 2-37
Exhibit 2-21: Stryker net sales, by product category and geography ($m), 2019–21………………….. 2-38
Exhibit 2-22: Zimmer Biomet net sales, by product category and geography ($m), 2019–21 ……………………………………………………………………………………………………….. 2-41
Exhibit 2-23: NuVasive net sales, by product category and geography ($000s), 2019–21…………… 2-42
Exhibit 2-24: Globus Medical net sales, by product category and geography ($000s), 2019–21 ……………………………………………………………………………………………………….. 2-43
COMPANY LISTING……………………………………………………………………………………………………………………………. A-1
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Market Spotlight: Lysosomal Storage Disorders 
Sign up to the